Shu Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shu Yao has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Dongyan Shi
Department of Immunology, Nanjing Medical University, Nanjing, China
2 shared publications - Hong Zhou
State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, 211166, China; Department of Immunology, Nanjing Medical University, Nanjing, 211166, China
2 shared publications - Lixin Liu
Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
2 shared publications - Fengjiao Wu
Interdisciplinary Eye Research Institute (EYE‐X Institute), Anhui Provincial Key Laboratory of Immunology in Chronic Diseases, Anhui Province Key Laboratory of Basic and Translational Research of Inflammation‐Related Diseases, Anhui Provincial Key Laboratory of Infection and Immunology, Department of Immunology, School of Basic Medical Sciences, Bengbu Medical University Bengbu China
1 shared publication - Jiahui Lu
Department of Immunology, Nanjing Medical University, 101 Longmian Avenue, Nanjing, 211166, JS, China
1 shared publication - Jun Hua
Department of Clinical Pharmacy, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, ShenZhen, China
1 shared publication
Latest Publications
- Open Access
- 6 August 2024
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 19 (1) , 1-3
Correction: FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
- 6 August 2024
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 19 (1) , 1-3
Open AccessCorrection: FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
- Open Access
- 4 May 2018
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 15 (1) , 136
IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
Interleukin-33 (IL-33) is increasingly being recognized as a key immunomodulatory cytokine in many neurological diseases. In the present study, wild-type (WT) and IL-33−/− mice received intracerebroventricular (i.c.v.) injection of lipopolysaccharide (LPS) to induce neuroinflammation. Intravital microscopy was employed to examine leukocyte–endothelial interactions in the brain vasculature. The degree of neutrophil infiltration was determined by myeloperoxidase (MPO) staining. Real-time PCR and western blotting were used to detect endothelial activation. Enzyme-linked immunosorbent assay and quantitative PCR were conducted to detect pro-inflammatory cytokine levels in the brain. In IL-33−/− mice, neutrophil infiltration in the brain cortex and leukocyte–endothelial cell interactions in the cerebral microvessels were significantly decreased as compared to WT mice after LPS injection. In addition, IL-33−/− mice showed reduced activation of microglia and cerebral endothelial cells. In vitro results indicated that IL-33 directly activated cerebral endothelial cells and promoted pro-inflammatory cytokine production in LPS-stimulated microglia. Our study indicated that IL-33/ST2 signaling plays an important role in the activation of microglia and cerebral endothelial cells and, therefore, is essential in leukocyte recruitment in brain inflammation. The role of IL-33/ST2 in LPS induced neuroinflammation
- 4 May 2018
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 15 (1) , 136
Open AccessIL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
Interleukin-33 (IL-33) is increasingly being recognized as a key immunomodulatory cytokine in many neurological diseases. In the present study, wild-type (WT) and IL-33−/− mice received intracerebroventricular (i.c.v.) injection of lipopolysaccharide (LPS) to induce neuroinflammation. Intravital microscopy was employed to examine leukocyte–endothelial interactions in the brain vasculature. The degree of neutrophil infiltration was determined by myeloperoxidase (MPO) staining. Real-time PCR and western blotting were used to detect endothelial activation. Enzyme-linked immunosorbent assay and quantitative PCR were conducted to detect pro-inflammatory cytokine levels in the brain. In IL-33−/− mice, neutrophil infiltration in the brain cortex and leukocyte–endothelial cell interactions in the cerebral microvessels were significantly decreased as compared to WT mice after LPS injection. In addition, IL-33−/− mice showed reduced activation of microglia and cerebral endothelial cells. In vitro results indicated that IL-33 directly activated cerebral endothelial cells and promoted pro-inflammatory cytokine production in LPS-stimulated microglia. Our study indicated that IL-33/ST2 signaling plays an important role in the activation of microglia and cerebral endothelial cells and, therefore, is essential in leukocyte recruitment in brain inflammation. The role of IL-33/ST2 in LPS induced neuroinflammation